Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: Results from the KING observational study of the Italian Society for Rheumatology (SIR)

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Scirè, Carlo A ^a,b   Manara, Maria ^a   Cimmino, Marco A ^c   Govoni, Marcello ^d   Salaffi, Fausto ^e   Punzi, Leonardo ^f   Monti, Maria C ^b   Carrara, Greta ^a   Montecucco, Carlomaurizio ^b   Matucci Cerinic, Marco ^g   Minisola, Giovanni ^h   Galossi, Alessandra ^g   Lauriti, Ciro ⁱ   Fracassi, Elena ^j   Selvi, Enrico ^k   Tirri, Enrico ^l   Furini, Federica ^d   Inverardi, Flora ^b   Porta, Francesco ^m   Venturino, Francesco ⁿ   Capsoni, Franco ^o   Sebastiani, Giandomenico ^h   Fabbriciani, Gianluigi ^p   D'Avola, Giovanni ⁿ   Botticella, Giulia ^c   Seminara, Giulia ^q   D'Alessandro, Giuseppe ^r   Santo, Leonardo ^s   Longato, Lorena ^t   Sinigaglia, Luigi ^u   Atteritano, Marco ^v   Broggini, Marco ^w   Caprioli, Marta ^x   Favero, Marta ^y   Sallì, Salvatore ^z   Parisi, Simone ^aa   Corvaglia, Stefania ^ab   Veneto, Vittorio ^ac   more..

^a Epidemiology Unit   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g Department of Medicine and Denothe Centre ^*  (Italy)

^h SAN CAMILLO FORLANINI HOSPITAL   (Italy)

ⁱ Ospedale Civile di Pescara   (Italy)

^j UNIVERSITY OF VERONA   (Italy)

^k UNIVERSITY HOSPITAL OF SIENA   (Italy)

^l Ospedale San Giovanni Bosco   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ Rheumatology Unit   (Italy)

^o UNIVERSITY OF MILAN   (Italy)

^p HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^q Rheumatology Unit   (Italy)

^r SS di Malattie Apparato Osteoarticolare ed Immunoproliferative   (Italy)

^s ASL BT DSS 4 Barletta   (Italy)

^t ASL Biella   (Italy)

^u ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^v UNIVERSITY OF MESSINA   (Italy)

^w OSPEDALE DI CIRCOLO   (Italy)

^x UO di Medicina Interna   (Italy)

^y UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^z UNIVERSITY OF PALERMO   (Italy)

^aa CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^ab UNIVERSITY OF BOLOGNA   (Italy)

^ac Rheumatology Unit   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MENTAL COMPONENT SUMMARY SCORE; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY; PHYSICAL COMPONENT SUMMARY SCORE; QUALITY OF LIFE; REGISTER; RHEUMATOLOGY; RISK FACTOR; SCORING SYSTEM; SHORT FORM 36; AGED; DISABILITY; HEALTH STATUS; METHODOLOGY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; QUESTIONNAIRE; STATISTICS;

AGED; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; GOUT; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RHEUMATOLOGY; RISK FACTORS;

EID: 84883718269     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4281     Document Type: Article

References (35)

1. Smith EU, az-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 2010, 24:811-827. 10.1016/j.berh.2010.10.004, 21665128.
2. Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2013, 72:694-700. 10.1136/annrheumdis-2011-201254, 22736095.
3. Salaffi F, De AR, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005, 23:819-828.
4. Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, Joseph-Ridge N. The economic burden of gout on an employed population. Curr Med Res Opin 2006, 22:1381-1389. 10.1185/030079906X112606, 16834837.
5. ten Klooster PM, Vonkeman HE, van de Laar MA. Disability due to gouty arthritis. Curr Opin Rheumatol 2012, 24:139-144. 10.1097/BOR.0b013e32834ff59d, 22227879.
6. Lottmann K, Chen X, Schadlich PK. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep 2012, 14:195-203. 10.1007/s11926-011-0234-2, 3297741, 22350606.
7. Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 2012, 125:679-687. 10.1016/j.amjmed.2011.09.033, 22626509.
8. Kim SY, Choi HK. Gout and quality of life. J Rheumatol 2009, 36:865-868. 10.3899/jrheum.090034, 19435969.
9. Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T. Gout: why is this curable disease so seldom cured?. Ann Rheum Dis 2012, 71:1765-1770. 10.1136/annrheumdis-2012-201687, 22863577.
10. Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, Neogi T, Gaffo AL, Becker MA, MacDonald PA, Dabbous O, Strand V, Dalbeth ND, Aletaha D, Edwards NL, Schumacher HR. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 2011, 38:1452-1457. 10.3899/jrheum.110271, 21724715.
11. Stamp LK, Khanna PP, Dalbeth N, Boers M, Maksymowych WP, Schumacher HR, Becker MA, MacDonald PA, Edwards NL, Singh JA, Simon LS, McQueen FM, Neogi T, Gaffo AL, Strand V, Taylor WJ. Serum urate in chronic gout - will it be the first validated soluble biomarker in rheumatology?. J Rheumatol 2011, 38:1462-1466. 10.3899/jrheum.110273, 3645864, 21724717.
12. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 2007, 46:1441-1444. 10.1093/rheumatology/kem150, 17586863.
13. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008, 67:1310-1316.
14. Alvarez-Nemegyei J, Cen-Piste JC, Medina-Escobedo M, Villanueva-Jorge S. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout. J Rheumatol 2005, 32:1923-1927.
15. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007, 46:1804-1807. 10.1093/rheumatology/kem246, 17982165.
16. Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B, Sundy JS. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009, 36:1041-1048. 10.3899/jrheum.071229, 19332629.
17. Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) 2009, 48:582-586. 2722803, 19307257.
18. Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford) 2011, 50:740-745. 10.1093/rheumatology/keq346, 3060621, 21147824.
19. Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 2011, 63:1605-1612. 10.1002/acr.20570, 22034122.
20. Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol 2003, 30:697-704.
21. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003, 49:156-163. 10.1002/art.10993, 12687505.
22. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009, 7:25. 10.1186/1477-7525-7-25, 2674445, 19296831.
23. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900. 10.1002/art.1780200320, 856219.
24. Ranza R, Marchesoni A, Calori G, Bianchi G, Braga M, Canazza S, Canesi B, Fumagalli M, Mastaglio C, Mathieu A, et al. The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 1993, 11:123-128.
25. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998, 51:1025-1036. 10.1016/S0895-4356(98)00094-8, 9817120.
26. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003, 1:20. 10.1186/1477-7525-1-20, 165587, 12831398.
27. Scirè CA, Verstappen SM, Mirjafari H, Bunn DK, Lunt M, Montecucco C, Bruce IN, Symmons DP. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2011, 63:945-952. 10.1002/acr.20453, 3149122, 21337726.
28. Apolone G, Mosconi P, Ware J. Questionnaire on health status SF-36 - User manual and a guide to interpretation of the results 1997, Milano: Guerini e Associati;.
29. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1167-1170. 10.1016/S0895-4356(98)00108-5, 9817134.
30. Strand V, Khanna D, Singh JA, Forsythe A, Edwards NL. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol 2012, 39:1450-1457. 10.3899/jrheum.111375, 22660805.
31. Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology (Oxford) 2009, 48(Suppl 2):ii9-ii14.
32. Humphreys JH, Verstappen SM, Mirjafari H, Bunn D, Lunt M, Bruce IN, Symmons DP. Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2013, 65:122-126. 10.1002/acr.21722, 3568899, 22556112.
33. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011, 30:377-399. 10.1002/sim.4067, 21225900.
34. Hirsch JD, Lee SJ, Terkeltaub R, Khanna D, Singh J, Sarkin A, Harvey J, Kavanaugh A. Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol 2008, 35:2406-2414. 10.3899/jrheum.080506, 18925685.
35. Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, Kavanaugh A, Lee SJ. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas 2010, 2010:1-8. 3113652,3113652, 21686040.